Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesIzotropic Corporation

Izotropic Corporation

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.125 CAD 0.00(0%)
Last update at 2026-11-10T17:29:00Z
VOLUME
127
Market Cap
18.63M

Momentum Score

…

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.12
Low
0.12
High
52 Week Price Range
0.19
Low
0.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Izotropic Corporation (IZO.CN) is limited, and available sources do not clearly describe the company's core operations. As a result, long-term growth drivers are not well documented; investors should monitor official filings, product disclosures and partnerships that, if demonstrated, could support future revenue and valuation.

The most important investment risks are uncertainty around the company's business model and revenue generation, thin market liquidity, and high execution and regulatory risk typical of small or early-stage issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
-0.05M
Debt / Equity
-
ROE
-37440.35%
Net Debt
2.48M
ROCE
45.62%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Income before tax -3.14M -1.56M -5.66M -6.65M -4.98M
Net income -3.14M -1.56M -5.66M -6.65M -4.98M
Selling general administrative 1.35M 0.70M 2.74M 3.16M 3.90M
Reconciled depreciation 0.05M 0.06M 0.03M 0.01M 0.00M
Ebit - - -5.23M -6.35M -4.82M
Ebitda - - -5.34M -6.63M -4.97M
Operating income -2.22M -1.70M -5.33M -6.64M -4.98M
Interest expense 0.29M 0.25M 0.29M 0.02M 0.00M
Net interest income -0.29M -0.25M -0.30M -0.02M 0.00M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 2.22M 1.70M 5.33M 6.64M 4.98M
Total other income expense net -0.64M 0.39M -0.03M -0.02M -
Net income from continuing ops -3.14M -1.56M -5.66M -6.65M -4.98M
Net income applicable to common shares - - -5.66M -6.65M -4.98M
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Total assets 0.41M 0.23M 0.44M 2.27M 4.69M
Other current assets - - 0.01M 0.02M 0.51M
Total liab 5.27M 4.08M 3.52M 2.64M 0.17M
Total stockholder equity -4.86M -3.85M -3.07M -0.37M 4.52M
Common stock - - 13.35M 11.28M 10.04M
Capital stock 15.12M 14.09M 13.35M 11.28M 10.04M
Retained earnings -22.14M -19.10M -18.09M -13.98M -7.33M
Cash 0.27M 0.04M 0.17M 1.86M 4.06M
Total current liabilities 5.27M 4.06M 3.46M 2.64M 0.17M
Net debt 2.48M 1.96M 1.88M 0.17M -
Short long term debt 2.75M 2.00M 2.05M 2.03M -
Other stockholder equity - - 1.66M 2.33M 1.80M
Property plant equipment - - 0.12M 0.02M 0.00M
Total current assets 0.40M 0.17M 0.32M 2.25M 4.69M
Net tangible assets - - -3.07M -0.37M 4.52M
Net receivables - - 0.01M 0.04M 0.04M
Accounts payable 2.45M 1.79M 1.15M 0.38M 0.09M
Non current assets total 0.02M 0.07M 0.12M 0.02M 0.00M
Capital lease obligations 0.02M 0.06M 0.09M 0.00M -
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Investments -0.00M 0.00M -0.04M -0.02M 0.00M
Change to liabilities - - 0.68M 0.45M 0.10M
Total cashflows from investing activities - - -0.04M -0.02M -0.02M
Net borrowings -0.05M -0.09M -0.02M 2.05M 2.05M
Total cash from financing activities 0.87M 0.47M 1.61M 2.58M 6.53M
Change to operating activities - - 0.24M 0.23M -0.46M
Net income -3.14M -1.56M -5.66M -6.65M -4.98M
Change in cash 0.24M -0.13M -1.69M -2.21M 3.45M
Begin period cash flow 0.04M 0.17M 1.86M 4.06M 0.61M
End period cash flow 0.27M 0.04M 0.17M 1.86M 4.06M
Total cash from operating activities -0.64M -0.59M -3.27M -4.76M -3.08M
Issuance of capital stock 0.92M 0.71M 1.81M 0.53M 5.77M
Depreciation 0.05M 0.06M 0.03M 0.01M 0.00M
Dividends paid 0.00M 0.00M 0.00M 0.00M -
Other cashflows from financing activities - - -0.22M -0.01M -0.19M
Change to netincome - - 1.44M 1.21M 2.25M
Capital expenditures 0.00M 0.00M 0.04M 0.02M 0.02M
Change in working capital 0.67M 0.21M 0.92M 0.67M -0.36M
Stock based compensation 0.92M 0.08M 1.15M 1.19M 2.25M
Other non cash items 0.29M 0.62M 0.29M 0.02M -
Free cash flow -0.64M -0.59M -3.30M -4.79M -3.08M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
IZO
Izotropic Corporation		 -
-%		 0.12 - 2.27 - 114.27 -5.29
BUX
BioMark Diagnostics Inc		 -0.03
6.67%		 0.42 - - 664.18 119.98 -27.36
SONA
Sona Nanotech Inc		 -
-%		 0.28 - - 495.02 110.83 54.97

Profile*

Izotropic Corporation

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

800-15355 24th Avenue, Surrey, BC, Canada, V4A 2H9

(833) 496-2677

https://izocorp.com

Name Title Year Born
Mr. Robert Louis Thast Founder, Interim CEO & Chairman 1954
Mr. Ralph F. Proceviat CPA CFO & Director 1950
Dr. Younes Achkire Ph.D. Executive VP of Product Engineering & COO NA
Mr. Ali Reza Sodagar Legal Advisor & Independent Director NA
Dr. Andrew M. Hernandez Head of Imaging Technology NA
Ms. Jaclyn Thast Operations Manager & Corporate Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…